Cha Albert Insider Trades

Insider Trading History

Track insider trading activity for Cha Albert. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
Director
Holding Value $809k 3,730 shares
Last Trade
Mar 18, 2026 Sale
$4.42M 19,445 shares
$227.41
$216.79
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $270k 10,000 shares
Last Trade
Sep 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$101k 10,000 shares
$10.08
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $485k 18,000 shares
Last Trade
Sep 11, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$190k 18,000 shares
$10.54
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $0 0 shares
Last Trade
Sep 11, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$189k 18,000 shares
$10.50
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $0 0 shares
Last Trade
Sep 11, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$190k 18,000 shares
$10.54
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $270k 10,000 shares
Last Trade
Oct 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.3k 10,000 shares
$4.53
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $270k 10,000 shares
Last Trade
Sep 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 10,000 shares
$17.45
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $30.7M 1,138,179 shares
Last Trade
Oct 30, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.99M 115,686 shares
$17.24
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $189k 7,000 shares
Last Trade
Oct 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90.2k 7,000 shares
$12.88
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $189k 7,000 shares
Last Trade
Oct 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78.5k 7,000 shares
$11.21
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $27.6M 1,022,493 shares
Last Trade
Jul 29, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$512k 29,867 shares
$17.13
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $26.9M 997,763 shares
Last Trade
Jul 26, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$446k 26,500 shares
$16.83
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $26.3M 975,821 shares
Last Trade
Jul 19, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.07M 60,000 shares
$17.81
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $25M 926,141 shares
Last Trade
Jul 17, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$21.7k 1,280 shares
$16.96
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $189k 7,000 shares
Last Trade
Oct 03, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$159k 7,000 shares
$22.65
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Director
Holding Value $36.6M 1,359,149 shares
Last Trade
Sep 10, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$18M 1,058,824 shares
$17.00
$26.95
Biohaven
Biohaven BHVN
Director
Holding Value $195k 18,000 shares
Last Trade
May 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$518k 18,000 shares
$28.76
$10.81
Biohaven
Biohaven BHVN
Director
Holding Value $22.2M 2,049,545 shares
Last Trade
Mar 14, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2M 72,727 shares
$27.50
$10.81
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $2.31M 3,524,541 shares
Last Trade
Jan 29, 2018 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$124M 3,717,118 shares
$33.39
$0.66
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $0 0 shares
Last Trade
Jan 29, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$40.6M 1,216,601 shares
$33.39
$0.66

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up